|
Massachusetts Dana-Farber Cancer Institute, Boston News is an EIN News Service for health professionals. Constantly updated news and information about Massachusetts Health.
Latest Massachusetts Dana-Farber Cancer Institute, Boston News
- Making Health Care Better 7 Nov 2009 05:58 GMT
... “I've wanted to go for years,” Janet Porter, the chief operating officer of the Dana-Farber Cancer Institute in Boston, told me later. For anybody interested in improving the quality of health ...
- Dana-Farber Cancer Institute Selects Plateau Systems' Integrated Talent Management Suite 6 Nov 2009 12:33 GMT
... , a leading provider of enterprise-class SaaS solutions for , announced that Dana-Farber Cancer Institute, one of the leading cancer research and care centers in the United States, has ...
- Bat Mobile at benefit Nov. 8 6 Nov 2009 12:35 GMT
... Ever wanted to see the world's most famous car up close? Well, now's ... will be hosting a benefit for the Dana Farber Cancer Institute at 19 Chestnut Street. And the benefit ...
- Transgenomic, Inc. Reports Third Quarter 2009 Results 6 Nov 2009 13:32 GMT
... in operating expenses was $0.2 million related to the license for Cold-PCR from the Dana-Farber Cancer Institute. Cash and cash equivalents totaled $4.7 million at September 30, 2009 compared to $4.8 ...
- Magazine Preview: Making Health Care Better 6 Nov 2009 02:07 GMT
... “I've wanted to go for years,” Janet Porter, the chief operating officer of the Dana-Farber Cancer Institute in Boston, told me later. For anybody interested in improving the quality of health ...
- Agennix AG Shares Begin Trading on Frankfurt Stock Exchange Company Provides Business Update 6 Nov 2009 09:28 GMT
... MARTINSRIED/MUNICH, GERMANY and PRINCETON, NJ and HOUSTON, TX -- (Marketwire) -- 11/06/09 -- Agennix AG (FRANKFURT: AGX) ...
- Agennix AG Shares Begin Trading on Frankfurt Stock Exchange 6 Nov 2009 09:34 GMT
... Agennix AG Shares Begin Trading on Frankfurt Stock Exchange MARTINSRIED/MUNICH, GERMANY and PRINCETON, NJ and HOUSTON, TX--(Marketwire - November ...
- ZIOPHARM Presents Positive Palifosfamide Sarcoma Randomized Phase II Interim Data at Annual Meeting of the Connective Tissue Oncology Society 6 Nov 2009 12:31 GMT
... of the Center for Sarcoma and Bone Oncology and the Ludwig Center at the Dana-Farber Cancer Institute and Harvard Medical School, and a member of ZIOPHARM's Medical Advisory Board, whose experience ...
- Positive interim data from the multicenter randomized Phase II trial of palifosfamide presented 6 Nov 2009 12:58 GMT
... of the Center for Sarcoma and Bone Oncology and the Ludwig Center at the Dana-Farber Cancer Institute and Harvard Medical School, and a member of ZIOPHARM’s Medical Advisory Board, whose experience ...
- A case of adult metastatic Xp11 translocation renal cell carcinoma treated successfully with sunitinib 6 Nov 2009 13:42 GMT
... Dana-Farber Cancer Institute, Boston, MA Brigham and Women's Hospital, Boston, MA. Renal cell carcinomas (RCC) associated with ...
- Ziopharm Presents Positive Palifosfamide Sarcoma Randomized Phase II Interim Data 6 Nov 2009 13:55 GMT
... George Demetri, director of Center for Sarcoma and Bone Oncology and Ludwig Center at Dana-Farber Cancer Institute and Harvard Medical School, said: “These interim results are very promising, indicating a potentially ...
- Framingham man to be honored tonight by the American Cancer Society 6 Nov 2009 15:48 GMT
... hosting a golf tournament at the Framingham Country Club in August, raising $50,000 for Dana-Farber Cancer Institute to go to breast cancer research. Sullivan, a professional boxing promoter in Providence, said ...
- Phase Forward Named Private Sector Company of the Year by Mass Technology Leadership Council 6 Nov 2009 18:31 GMT
... study participants at over 300 organizations and regulatory agencies worldwide including: AstraZeneca, Boston Scientific, Dana-Farber Cancer Institute, Eli Lilly, the U.S. Food and Drug Administration, GlaxoSmithKline, Harvard Clinical Research Institute, Merck ...
- MEDBIZONICS, LLC Announces Recent Acquisitions 6 Nov 2009 19:16 GMT
... study participants at over 300 organizations and regulatory agencies worldwide including: AstraZeneca, Boston Scientific, Dana-Farber Cancer Institute, Eli Lilly, the U.S. Food and Drug Administration, GlaxoSmithKline, Harvard Clinical Research Institute, Merck ...
- Phase Forward Named Private Sector Company of the Year by Mass Technology Leadership Council 6 Nov 2009 19:30 GMT
... study participants at over 300 organizations and regulatory agencies worldwide including: AstraZeneca, Boston Scientific, Dana-Farber Cancer Institute, Eli Lilly, the U.S. Food and Drug Administration, GlaxoSmithKline, Harvard Clinical Research Institute, Merck ...
Powered by 
Massachusetts Health News Sections
These stories are not published by IPD Group, Inc. and these links will take you to other websites. Some of these websites require their own registration to read their stories.
<<< Please read the disclaimer for more details.>>> | |
Healthcare Industry Today
|
a digital news provider
>
Dana-Farber Cancer Institute, Boston
bbc.co.uk:
healthday.com:
reuters.com: